Pharmaceutical research and development (R&D) organizations were early adopters who recognized the many benefits of UltraPerformance LC? (UPLC?) Technology including resolution, sensitivity, throughput, and productivity as compared to HPLC.
This article aims to demonstrate a novel accelerated method development approach to develop HPLC and/or UPLC methods